Literature DB >> 15352895

Review article: patients' fears and unmet needs in inflammatory bowel disease.

E J Irvine1.   

Abstract

The management of chronic illness is becoming increasingly patient-centred. Although patients with inflammatory bowel disease have a normal life expectancy, most individuals experience an impact of inflammatory bowel disease on their daily lives as well as on their attitudes, fears and beliefs. Although currently available therapies for ulcerative colitis and Crohn's disease are becoming increasingly effective, there are still many unmet needs to address in this patient population. Physicians and patients' spouses or significant others underestimate the type and severity of problems reported by inflammatory bowel disease patients. Physical problems are frequently measured using disease activity indices. Emotional and social problems are reported using quality of life questionnaires and other specific measurement tools pertinent to the question of interest. Studies have indicated a poorer physical and emotional function in inflammatory bowel disease patients than in the general population. Effective therapies, both medical and surgical, produce significant improvements in the general and disease-specific quality of life. The quality of life is worse when the disease is more severe. Concomitant anxiety or depression appears to impair the quality of life even further. Common fears include the possibility of unanticipated flares, the need for surgery, poor energy levels and the side-effects of medication. Recent studies have suggested that more prominent patient participation in management has the potential for greater patient satisfaction, better outcomes and more efficient health resource utilization. Thus, future studies should focus not only on ensuring the wider availability of effective therapies, but on increasing access to health care that is tailored to individuals--more structure for some and more independence and self-management for others, with health provider supervision.

Entities:  

Mesh:

Year:  2004        PMID: 15352895     DOI: 10.1111/j.1365-2036.2004.02053.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  24 in total

1.  Postoperative complications have little influence on long-term quality of life in Crohn's patients.

Authors:  Michael S Kasparek; Joerg Glatzle; Mario H Mueller; Andreas Schneider; Alfred Koenigsrainer; Martin E Kreis
Journal:  J Gastrointest Surg       Date:  2007-11-28       Impact factor: 3.452

2.  Coping strategy when patients with quiescent Crohn's disease recognize that their conditions are worsening.

Authors:  Makoto Tanaka; Yasushi Iwao; Susumu Okamoto; Haruhiko Ogata; Toshifumi Hibi; Keiko Kazuma
Journal:  J Gastroenterol       Date:  2009-07-16       Impact factor: 7.527

3.  Understanding gastrointestinal distress: a framework for clinical practice.

Authors:  Brennan M R Spiegel; Dinesh Khanna; Roger Bolus; Nikhil Agarwal; Puja Khanna; Lin Chang
Journal:  Am J Gastroenterol       Date:  2011-03       Impact factor: 10.864

4.  An 18-month study of the effects of IBD symptomatology and emotion regulation on depressed mood.

Authors:  Inês A Trindade; Cláudia Ferreira; Mariana Moura-Ramos; José Pinto-Gouveia
Journal:  Int J Colorectal Dis       Date:  2017-02-09       Impact factor: 2.571

5.  Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Munira Essat; Paul Tappenden; Shijie Ren; Alice Bessey; Rachel Archer; Ruth Wong; Alan Lobo; Sami Hoque
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

6.  Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Christopher Ma; Nicola R Panaccione; Tran M Nguyen; Leonardo Guizzetti; Claire E Parker; Isra M Hussein; Niels Vande Casteele; Reena Khanna; Parambir S Dulai; Siddharth Singh; Brian G Feagan; Vipul Jairath
Journal:  J Crohns Colitis       Date:  2019-09-19       Impact factor: 9.071

7.  Health-related quality of life in inflammatory bowel disease measured with the generic 15D instrument.

Authors:  Johanna Haapamäki; Risto P Roine; Harri Sintonen; Ulla Turunen; Martti A Färkkilä; Perttu E T Arkkila
Journal:  Qual Life Res       Date:  2010-04-02       Impact factor: 4.147

Review 8.  Exercise and Crohn's disease: speculations on potential benefits.

Authors:  Victor Ng; Wanda Millard; Constance Lebrun; John Howard
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

Review 9.  Anxiety and medical disorders.

Authors:  Jacqueline E Muller; Liezl Koen; Dan J Stein
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

10.  Ulcerative Colitis Symptomatology and Depression: The Exacerbator Role of Maladaptive Psychological Processes.

Authors:  Inês A Trindade; Cláudia Ferreira; José Pinto-Gouveia
Journal:  Dig Dis Sci       Date:  2015-07-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.